Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Appointed COO
|
|
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 08/04/2023 |
4
| Lebovits Chaim (President & CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 31,185 shares
@ $0 |
|
| 05/01/2023 |
4
| Taylor Kirk (Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,000 shares
@ $0
Granted 80,000 options to buy
@ $2.99, valued at
$239.2k
|
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Lindborg Stacy (Co-CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 01/04/2023 |
4
| Lebovits Chaim (CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 31,185 shares
@ $0 |
|
| 04/08/2022 |
4
| FRENKEL JACOB A (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 50,000 options to buy
@ $0.75, valued at
$37.5k
|
|
| 03/14/2022 |
4
| Kern Ralph Dr. (COO and Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,885 shares
@ $0 |
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| TAUB MALCOLM S (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 12/17/2021 |
4
| Polverino Anthony J. (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 2,000 shares
@ $0 |
|
| 12/17/2021 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 2,000 shares
@ $0 |
|
| 12/17/2021 |
4
| Yablonka Uri (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 13,333 options to buy
@ $0.75, valued at
$10k
|
|
| 12/17/2021 |
4
| ARBEL IRIT (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 25,333 options to buy
@ $0.75, valued at
$19k
|
|
| 12/10/2021 |
4
| Kern Ralph Dr. (COO and Chief Medical Officer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 35,885 shares
@ $0 |
|
| 12/10/2021 |
4
| Lebovits Chaim (CEO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 31,185 shares
@ $0 |
|
| 12/10/2021 |
4
| TAUB MALCOLM S (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 12/10/2021 |
4
| Polverino Anthony J. (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 2,216 shares
@ $0
Granted 2,000 shares
@ $0 |
|
| 12/10/2021 |
4
| ARBEL IRIT (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 25,333 options to buy
@ $0.75, valued at
$19k
|
|
| 12/10/2021 |
4
| FRENKEL JACOB A (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 50,000 options to buy
@ $0.75, valued at
$37.5k
|
|
| 12/10/2021 |
4
| Abbhi Sankesh (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 6,666 shares
@ $0 |
|
| 12/10/2021 |
4
| Yablonka Uri (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 13,333 options to buy
@ $0.75, valued at
$10k
|
|
| 12/10/2021 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 2,000 shares
@ $0 |
|
| 12/31/2020 |
4
| Shah Preetam (EVP, CFO and Treasurer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 25,000 shares
@ $4.64, valued at
$116k
|
|
| 11/19/2020 |
4
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Bought 200 options to buy
@ $10, valued at
$2k
|
|
| 09/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Lindborg Stacy (EVP, Head Global Clin Research) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 25,000 shares
@ $0
Granted 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 04/07/2020 |
4
| Setboun David (EVP and COO) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 50,000 shares
@ $0 |
|
|
|
|